Gastrointestinal Stromal Tumor (GIST) News and Research

RSS
Gastrointestinal Stromal Tumor (GIST) is a type of tumor that usually begins in cells in the wall of the gastrointestinal tract. It can be benign or malignant.
Gleevec shows great promise in preventing cancer recurrence

Gleevec shows great promise in preventing cancer recurrence

Gleevec decreases cancer recurrence for GIST

Gleevec decreases cancer recurrence for GIST

Emerging threats demand new approach to disaster preparedness

Emerging threats demand new approach to disaster preparedness

Maraviroc to receive accelerated review in U.S. and Europe

Maraviroc to receive accelerated review in U.S. and Europe

Smart cancer drug on sale in the UK

Smart cancer drug on sale in the UK

Gleevec may cause heart problems

Gleevec may cause heart problems

Glivec the best news yet for cancer victims

Glivec the best news yet for cancer victims

Gleevec strangles drug-resistant, metastatic prostate cancer

Gleevec strangles drug-resistant, metastatic prostate cancer

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

Study confirms Gleevec's long-term benefits in treating advanced gastrointestinal stromal tumors

Study confirms Gleevec's long-term benefits in treating advanced gastrointestinal stromal tumors

Sunitinib therapy shows promise in children with metastatic gastrointenstinal stromal tumor

Sunitinib therapy shows promise in children with metastatic gastrointenstinal stromal tumor

Cancer treatment interferes with bone development

Cancer treatment interferes with bone development

New way to study proteins in live cells

New way to study proteins in live cells

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

New study demonstrates high rates of tumor death in patients receiving regimen

New study demonstrates high rates of tumor death in patients receiving regimen

Why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa)

Why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa)

Imatinib mesylate (Gleevec) inhibits important pathways that spur cancer growth

Imatinib mesylate (Gleevec) inhibits important pathways that spur cancer growth

Twice daily Imatinib could improve outcome for people with specific form of gastro-intestinal cancer

Twice daily Imatinib could improve outcome for people with specific form of gastro-intestinal cancer

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

Developing smart drugs

Developing smart drugs